|
|
|
1 |
Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging - Corrected Proof
|
4 |
|
2 |
Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus - Corrected Proof
|
1 |
|
3 |
Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory study - Corrected Proof
|
1 |
|
4 |
Medical and environmental risk factors associated with frontotemporal dementia: A case-control study in a veteran population - Corrected Proof
|
1 |
|
5 |
Gaining precision on the Alzheimer’s Disease Assessment Scale-cognitive: A comparison of item response theory-based scores and total scores - Corrected Proof
|
1 |
|
6 |
Fire in the ashes: Can failed Alzheimer’s disease drugs succeed with second chances? - Corrected Proof
|
1 |
|
7 |
Alzheimer’s disease: Pathogenesis and prevention - Corrected Proof
|
1 |
|
8 |
Butyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotype - Corrected Proof
|
29 |
|
9 |
Intraindividual cognitive decline using a brief computerized cognitive screening test
|
5 |
|
10 |
Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease
|
5 |
|
11 |
Psychosocial stress at work is associated with increased dementia risk in late life
|
11 |
|
12 |
2012 Alzheimer’s disease facts and figures
|
9 |
|
13 |
Alzheimer’s Association Update March 2012
|
8 |
|
14 |
Contents
|
4 |
|
15 |
Editorial Board
|
6 |
|
16 |
Medical and Scientific Advisory Council
|
4 |
|
17 |
Subscriber information
|
6 |
|
18 |
Global gray matter changes in posterior cortical atrophy: A serial imaging study - Corrected Proof
|
16 |
|
19 |
Environmental Factors Preceding Aβ40 Monomer to Oligomers and the Detection of Oligomers in Alzheimer's Disease Patient Serum
|
37 |
|
20 |
Herbal medicines for the prevention and treatment of Alzheimer's disease.
|
26 |
|
21 |
Hope For Early Alzheimer's Test In Spinal Fluid
|
23 |
|
22 |
Depressive symptoms and level of physical activity in patients with Alzheimer's disease. - Vital TM, Hernandez SS, Stein AM, Garuffi M, Corazza DI, Andrade LP, Costa JL, Stella F.
|
18 |
|
23 |
Dementia associated to paradichlorobenzene poisoning. - Gutierrez-Plascencia P, Ruiz-Sandoval MC, Martinez-Rocha M, Chiquete E, Zuniga-Ramirez C, Ruiz-Sandoval JL.
|
15 |
|
24 |
[Comment] Improving Alzheimer's disease outcomes in Down's syndrome
|
16 |
|
25 |
[Articles] Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
|
11 |
|
26 |
New findings on 'critical junction' in the brain could have implications for treating Alzheimer's
|
15 |
|
27 |
Alzheimer's Families Clamor for Drug
|
13 |
|
28 |
A β‐amyloid oligomer directly modulates P/Q‐type calcium currents in Xenopus oocytes
|
10 |
|
29 |
A possible breakthrough in Alzheimer's treatment
|
14 |
|
30 |
Cancer drug reverses Alzheimer's in mice
|
12 |
| |
|
Sida 1 av 107 |
